mRNA |
BRD1835 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
-0.093 |
0.002 |
mRNA |
pifithrin-mu |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.003 |
mRNA |
OSI-906 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.003 |
mRNA |
BRD-K45681478 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.004 |
mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
-0.16 |
0.005 |